Compare Unichem Lab with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB NATCO PHARMA UNICHEM LAB/
NATCO PHARMA
 
P/E (TTM) x -47.5 30.5 - View Chart
P/BV x 1.2 4.3 26.9% View Chart
Dividend Yield % 1.2 0.8 152.4%  

Financials

 UNICHEM LAB   NATCO PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
NATCO PHARMA
Mar-19
UNICHEM LAB/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs292849 34.4%   
Low Rs182557 32.7%   
Sales per share (Unadj.) Rs167.7573.8 29.2%  
Earnings per share (Unadj.) Rs-3.6176.0 -2.1%  
Cash flow per share (Unadj.) Rs5.9198.2 3.0%  
Dividends per share (Unadj.) Rs4.006.25 64.0%  
Dividend yield (eoy) %1.70.9 189.8%  
Book value per share (Unadj.) Rs372.3842.7 44.2%  
Shares outstanding (eoy) m70.3836.50 192.8%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x1.41.2 115.4%   
Avg P/E ratio x-65.34.0 -1,634.2%  
P/CF ratio (eoy) x39.93.5 1,124.5%  
Price / Book Value ratio x0.60.8 76.3%  
Dividend payout %-110.23.6 -3,102.4%   
Avg Mkt Cap Rs m16,68025,660 65.0%   
No. of employees `0002.65.0 52.5%   
Total wages/salary Rs m2,3933,559 67.2%   
Avg. sales/employee Rs Th4,535.24,225.3 107.3%   
Avg. wages/employee Rs Th919.8718.0 128.1%   
Avg. net profit/employee Rs Th-98.21,295.9 -7.6%   
INCOME DATA
Net Sales Rs m11,80120,945 56.3%  
Other income Rs m9841,302 75.6%   
Total revenues Rs m12,78522,247 57.5%   
Gross profit Rs m-8357,948 -10.5%  
Depreciation Rs m674810 83.2%   
Interest Rs m75193 39.0%   
Profit before tax Rs m-6008,247 -7.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,823 -18.8%   
Profit after tax Rs m-2566,424 -4.0%  
Gross profit margin %-7.137.9 -18.6%  
Effective tax rate %57.322.1 259.1%   
Net profit margin %-2.230.7 -7.1%  
BALANCE SHEET DATA
Current assets Rs m20,38423,472 86.8%   
Current liabilities Rs m5,0297,287 69.0%   
Net working cap to sales %130.177.3 168.4%  
Current ratio x4.13.2 125.8%  
Inventory Days Days10592 113.6%  
Debtors Days Days13588 152.9%  
Net fixed assets Rs m9,02318,648 48.4%   
Share capital Rs m141365 38.6%   
"Free" reserves Rs m26,05834,525 75.5%   
Net worth Rs m26,19930,760 85.2%   
Long term debt Rs m00-   
Total assets Rs m31,49643,031 73.2%  
Interest coverage x-7.043.7 -15.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.5 77.0%   
Return on assets %-0.615.4 -3.7%  
Return on equity %-1.020.9 -4.7%  
Return on capital %-2.027.4 -7.3%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18811,536 71.0%   
Fx outflow Rs m5962,939 20.3%   
Net fx Rs m7,5928,597 88.3%   
CASH FLOW
From Operations Rs m-3,2786,688 -49.0%  
From Investments Rs m-2,860-6,122 46.7%  
From Financial Activity Rs m-24-509 4.8%  
Net Cashflow Rs m-4,69066 -7,106.4%  

Share Holding

Indian Promoters % 50.1 52.0 96.3%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 15.1 7.8 192.6%  
FIIs % 3.0 16.6 18.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 26.0 121.9%  
Shareholders   20,176 25,395 79.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   BIOCON   CADILA HEALTHCARE  VENUS REMEDIES  PANACEA BIOTECH  WOCKHARDT  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 447 Points Higher; Automobile & IT Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours and ended today's volatile session higher.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 2, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS